Back to discover
Drug

Mirtazapine

In clinical development
Emerging researchLate-stage development
Also known as 6-Azamianserin, Mepirzapine, Mirataz, Remeron+4 more

6-Azamianserin, Mepirzapine, Mirataz, Remeron, Mirtazapin, Mirtazapina, 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine, Mirtazapinum.

1
Research papers
9
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Repurposing Mirtazapine in Rett Syndrome: a Multicentric Open Label Phase II Study

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

Preliminary Study to Explore the Effects of Mirtazapine on Appetite in Advanced Cancer Patients

Clinical trial2026-06-12Results expected Q4 2027 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Mirtazapine
Aliases & brands
6-AzamianserinMepirzapineMiratazRemeronMirtazapinMirtazapina1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepineMirtazapinum
RxNorm CUI
15996
ChEMBL ID
CHEMBL654
UNII
A051Q2099Q

Clinical trials

77 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
77
registered trials across all phases
LATEST COMPLETION 2025
9
Active studies
7
Recruiting
39
Late-stage (III+)
49
Completed
19
Discontinued
PHASE DISTRIBUTIONn = 77
Early Phase 14Phase 17Phase 1 / 22Phase 225Phase 2 / 32Phase 39Phase 420Phase N / A8

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Archives of general psychiatry · 2011 · 115 cites
Recent papers

Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Archives of general psychiatry · 2011 · 115 cites
Journals, researchers & institutions
Top journals
  • Archives of general psychiatry1
Leading researchers
  • Colfax GN1
  • Das M1
  • Gasper J1
  • Matheson T1
  • Santos DM1
  • Santos GM1
  • Shoptaw S1
  • Vittinghoff E1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials